Ingredient · Rare-Species Active Botanical

P. Ochra

P. ochraceocentrata

Family Hymenogastraceae · Compound class: tryptamine alkaloids (Active Botanical alkaloids, with proposed alkaloid-ratio differences from Active Botanical).

MYKO's rare-species Active Botanical reserved for EUPHORIA — premium positioning by formulation logic and rarity.

MYKO Spec
125mg per Capsule
Used In
EUPHORIA Only
Evidence
Tier 4 Emerging

A rare-species Active Botanical that anchors EUPHORIA — its premium positioning comes from sourcing, formulation intent, and intentional ritual use, not from clinical superiority over other species.

What It Is

A less common species reserved for one MYKO formula.

P. Ochra (P. Ochra) is a less common Active Botanical species from the Active Botanical family. MYKO sources it as a finished, dried, milled botanical — substantially rarer in commercial supply than the more widely cultivated Active Botanical.

P. Ochra's premium positioning in EUPHORIA comes from its rarity, careful sourcing, and intentional formulation context — not from any claim that its chemistry is clinically superior to other Active Botanical species. The character commonly described in community reports has not been definitively established in human research.

EUPHORIA is the only MYKO formula that uses P. Ochra. It is dosed at 125mg of dried botanical per capsule, alongside Reishi (12:1, 150mg), Chaga (9:1, 125mg), and Shilajit (100mg). MYKO products are not clinical treatments and have not been clinically evaluated for any condition.

Why MYKO Uses It

EUPHORIA's anchor — premium by sourcing, not by claim.

MYKO uses P. Ochra in EUPHORIA to anchor the formula's character: experiential openness in a contemplative, ritual context, grounded by a Reishi + Chaga restorative stack and supported by Shilajit's mineral matrix. The species was selected for its rarity, the formulation team's intentional decision to differentiate EUPHORIA from MYKO's cubensis-based formulas, and the sourcing care it demands — not for any claim of clinical superiority.

Found In MYKO Formulas

Where P. Ochra appears in the line.

EUPHORIA
The Spirit
125mg dried botanical · paired with Reishi + Chaga + Shilajit
View Formula →
Effects & Experience

Experiential and observational — never clinically established.

Customer descriptions of EUPHORIA are framed in community-observation language: warmth, embodied openness, gentle mood lift, smooth body feel. These descriptions are experiential and observational, not clinically established.

MYKO frames EUPHORIA as a premium contemplative ritual, not as a stronger or better-than experience versus the rest of the line.

Key Bioactive Compounds

The chemistry MYKO selects for.

  • Psilocybin
    Tryptamine prodrug — same molecule as in Active Botanical; the literature on absolute content in P. Ochra is limited and varies by lot.
  • Psilocin
    Active metabolite. Same 5-HT2A pharmacology profile as in Active Botanical.
  • Minor alkaloid profile
    Community-reported character differences may relate to subtle variation in alkaloid ratios across the genus, but this is poorly characterized in peer-reviewed literature.
  • Beta-glucans & ergosterol
    Fungal cell-wall and sterol compounds present in any whole-fruiting-body preparation.
Mechanisms in the Body

Three pathways, three evidence levels.

Mechanism strength is presented separately so you can see what is human-supported, what is preclinical, and what is traditional theory.

Human-Supported
  • There is no published clinical literature specific to P. Ochraceocentrata in humans. Mechanistic inferences are extrapolated from general Active Botanical research conducted on other species.
Preclinical / Mechanistic
  • Same overall 5-HT2A agonism mechanism shared across the Active Botanical family.
  • Subtle differences in alkaloid ratios across the genus may produce subtle differences in subjective character — an area of community observation, not established research.
Traditional / Theoretical
  • P. Ochraceocentrata does not have an established documented Indigenous lineage in the way Active Botanical-related species or P. mexicana-family preparations do. Community use is recent and experiential rather than ceremonially sustained.
Evidence Grade

How MYKO grades this ingredient.

Overall Grade
Tier 4 — emerging, observational, and experiential.
Strongest Areas
Pharmacology shared with the broader Active Botanical family (insofar as 5-HT2A agonism is well-characterized).
Weaker / Emerging
Species-specific human outcome literature; species-specific subjective-character claims; any claim that P. Ochra is clinically superior or different in outcome from Active Botanical.
Claim Caution
High
Reason
P. Ochra is currently a community-and-experiential ingredient. Its premium positioning is sourcing- and formulation-based, not evidence-based. All copy must respect that distinction.
Science Hub

For the customer who wants the full picture.

Read the Deeper Technical Version

P. Ochraceocentrata sits in the Active Botanical family and shares the broad 5-HT2A agonism pharmacology of the family. The species is materially rarer in commercial supply than Active Botanical, and the published human literature on it is essentially absent — alkaloid profiling exists at the species-survey level but not at the supplementation-trial level.

Within MYKO, P. Ochra is reserved for EUPHORIA at 125mg per capsule and paired with Reishi (12:1, 150mg) for parasympathetic tone, Chaga (9:1, 125mg) for antioxidant balance, and Shilajit (100mg) as the universal driver. The formulation logic is grounded and restorative — the goal is for the experience to feel embodied, not vaulted.

The brand's premium positioning is built on three things only: rarity of supply, sourcing care, and intentional formulation context. We do not claim that P. Ochra is clinically superior to other Active Botanical species. Subjective-character descriptions are framed as community observation, not as established outcomes.

All Active Botanical safety, contraindication, and cycling guidance applies in full. Because species-specific human safety data are limited, MYKO defers to the more conservative side of all Active Botanical safety language.

References

Direct human-outcome citations specific to this ingredient are limited or not yet referenced inline on this page. See the MYKO Ingredient Hub for the full evidence base, and the Science page for the broader formulation literature.

Safety Notes

What to know before using.

  • All Active Botanical contraindications apply with full force: Lithium (absolute), Bipolar I / psychosis history, MAOIs, SSRIs / SNRIs (response blunting and triple-serotonergic risk with Lion's Mane), pregnancy, cardiovascular conditions, surgery.
  • No species-specific human safety data — defer to the more conservative side of all Active Botanical safety guidance.
  • Cycling protocols (Stamets, Fadiman) apply.
  • Sourcing is more challenging for rare species — insist on documentation of identity, alkaloid testing, and chain-of-custody.
  • Legal status varies by jurisdiction. MYKO customers are responsible for verifying local applicable regulations.
  • MYKO products are not clinical treatments and have not been clinically evaluated for any condition.
Research Notes

What's supported, what's emerging.

What is reasonably supported: shared 5-HT2A pharmacology with the broader Active Botanical family.

What is still emerging: P. Ochra-specific alkaloid profiling; species-specific subjective character; long-term safety profile.

What should not be claimed strongly: "more euphoric than other species," "more therapeutic," "clinically superior," "safer because rare," or any species-specific outcome claim.

Where more human research is needed: virtually everything specific to this species in humans.

Where It Leads

Meet the formulas built on it.

Every MYKO ingredient earns its place in a formula. See the systems it powers — or find the one built for you.

Shop The Formulas Find Your Formula
Explore Ingredients

All Twelve in MYKO's Library.

Lion's Mane Cordyceps Shilajit Reishi Chaga Turkey Tail Active Botanical P. Ochra 5 Mushroom Complex Niacin · B3 Magnesium Glycinate Magnesium L-Threonate

These statements have not been evaluated by the U.S. Food and Drug Administration. MYKO products are not intended to diagnose, treat, cure, or prevent any disease.

Information on this site is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Consult a qualified healthcare practitioner before beginning any new supplement, particularly if you are pregnant, breastfeeding, taking medication, or managing a medical condition.